Advice

Following a full submission.

Emtricitabine (Emtriva) is not recommended for use within NHS Scotland for the treatment of HIV-1 infected adults and children. In combination with other antiretroviral agents it produces a viral response in treatment-naïve patients and those previously stabilised on other antiretrovirals. However, an economic evaluation was not provided, thus the economic case is not demonstrated.

Download detailed advice29KB (PDF)

Download

Medicine details

Medicine name:
Emtricitabine 200mg hard capsules (Emtriva®)
SMC ID:
105/04
Indication:
HIV-1 infected adults in combination with other antiretroviral agents
Pharmaceutical company
Gilead Sciences Ltd
BNF chapter
Infections
Submission type
Full
Status
Not recommended
Date advice published
12 July 2004